 | Up a level |
Doulberis, Michael; Papaefthymiou, Apostolis; Srivastava, David S.; Exadaktylos, Aristomenis K.; Katsinelos, Panagiotis; Kountouras, Jannis; Polyzos, Stergios A. (2021). Update on the association between non‐alcoholic fatty liver disease and Helicobacter pylori infection. International Journal of Clinical Practice, 75(4), e13737. Wiley 10.1111/ijcp.13737
Doulberis, Michael; Pierre, Noah Thierry; Manzini, Giulia; Papaefthymiou, Apostolis; Kountouras, Jannis; Klukowska-Rötzler, Jolanta; Polyzos, Stergios A.; Srivastava, Simone; Exadaktylos, Aristomenis K.; Knuchel, Jürg; Kuntzen, Thomas; Srivastava, David S. (2021). Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients. Microorganisms, 9(7), p. 1361. MDPI 10.3390/microorganisms9071361
Kountouras, Jannis; Doulberis, Michael; Papaefthymiou, Apostolis; Polyzos, Stergios A. (2020). Impact of Helicobacter pylori ‐linked metabolic syndrome on non‐alcoholic fatty liver disease and its connected atrial fibrillation risk. Liver international, 40(8), pp. 2036-2037. Wiley 10.1111/liv.14488
Polyzos, Stergios A; Kountouras, Jannis; Anastasilakis, Athanasios D; Makras, Polyzois; Hawa, Gerhard; Sonnleitner, Linda; Missbichler, Albert; Doulberis, Michael; Katsinelos, Panagiotis; Terpos, Evangelos (2018). Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment. Hormones, 17(4), pp. 573-579. Springer 10.1007/s42000-018-0083-8
